The Valley Desk

NCT06544265 · Interventional trial

SynKIR-310 for Relapsed/Refractory B-NHL

Overall registry status Recruiting

Phase 1

Conditions Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, DLBCL, DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation, DLBCL - Diffuse Large B Cell Lymphoma, Diffuse Large B Cell Lymphoma, Epstein-Barr Virus Positive DLBCL, Nos, Follicular Lymphoma, Follicular Lymphoma Grade 3, Follicular Lymphoma Grade 3B, HGBL With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Large B-cell Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Marginal Zone Splenic Lymphoma, NHL, Adult, Non-hodgkin Lymphoma,B Cell, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, T-Cell/Histiocyte Rich Lymphoma, Waldenstrom Macroglobulinaemia, Waldenstrom Macroglobulinemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov